Date:
Location:
Clinical Trials in the Era of Precision Medicine
A Dana-Farber Cancer Institute/Frontier Science Technology and Research Foundation Marvin Zelen Memorial Symposium
Dr. Lisa McShane, Ph.D. from the National Cancer Institute
Precision medicine: promise, innovation, trials and tribulations
Williams Sellers, M.D. from Novartis Institutes for BioMedical Research
Developing the Next Generation of Cancer Therapeutics
D. Neil Hayes, M.D., Ph.D. from the University of North Carolina at Chapel Hill
Precision Medicine for patients with advanced cancer: Basket trials, bucket trials, off-label therapies and other outcomes
Short talks by:
Eliezer Van Allen, M.D., Dana-Farber Cancer Institute and Harvard Medical School
Clinical computational oncology for precision cancer medicine
Robert Gray, Ph.D., Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health
The NCI MATCH Trial
Meredith Regan, Sc.D., Dana-Farber Cancer Institute and Harvard Medical School
Biomarker-Driven Trials in the International Breast Cancer Study Group
Lorenzo Trippa, Ph.D., Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health
Bayesian Baskets: A Design for Biomarker-Based Clinical Trials
Registration deadline March 30, 2016.
Reception to follow in the Yawkey Conference Center.